DNA encoding a human thrombomodulin having a modified glycosaminoglycan (GAG) binding site
US5354664A · kind A · utility
0Cited by
0References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 23, 1993 |
| Grant date | Oct 11, 1994 |
| Priority date | — |
| Expiry date | Aug 23, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Thrombin-binding substances capable of promoting anti-thrombin III activity and inhibiting platelet aggregation, and by themselves possessing anti-thrombin activity are disclosed. The thrombin-binding substances are useful as an effective component of anticoagulant agents, and can be produced inexpensively on a large scale.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.